Crow Point Partners’s Teladoc Health TDOC Stock Holding History

Crow Point Partners’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$262K	Sell	3,151 -2,943	-48%	-$224K	0.41%	54
2019 Q3	$405K	Sell	6,094 -1,271	-17%	-$83.7K	0.06%	76
2019 Q2	$489K	Buy	7,365 +1,271	+21%	+$74.1K	0.08%	63
2019 Q1	$339K	Hold	6,094	–	–	0.06%	78
2018 Q4	$295K	Sell	6,094 -367	-6%	-$22.5K	0.05%	84
2018 Q3	$558K	Sell	6,461 -734	-10%	-$52.3K	0.1%	75
2018 Q2	$415K	Buy	7,195 +5,799	+415%	+$283K	0.08%	74
2018 Q1	$56K	Buy	1,396 +59	+4%	+$2.23K	0.01%	184
2017 Q4	$47K	Buy	+1,337	New	+$44.4K	0.01%	213

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Crow Point Partners's TDOC Position: Q4 2019 in Review

Crow Point Partners reduced its Teladoc Health (TDOC) stake by 48% in Q4 2019, selling an estimated $224K and leaving 3,151 shares worth $262K. The position accounts for 0.41% of the portfolio, ranked #54.

Crow Point Partners first reported a position in TDOC in Q4 2017 and has held it in 9 quarters since. The position peaked at $558K in Q3 2018. 421 funds tracked by Wall St. Rank hold TDOC as of Q4 2019.

Crow Point Partners held 3,151 shares of Teladoc Health worth $262K as of Q4 2019.
Crow Point Partners sold 2,943 Teladoc Health shares in Q4 2019, an estimated $224K.
Teladoc Health made up 0.41% of Crow Point Partners's portfolio in Q4 2019, its #54 holding.
Crow Point Partners first reported a position in Teladoc Health in Q4 2017 and has held it in 9 quarters since.
Crow Point Partners's Teladoc Health position peaked at $558K in Q3 2018.
421 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2019.

Based on Crow Point Partners's 13F filing for Q4 2019, filed 14 Feb 2020.